Jane Street’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.4K Sell
20,569
-507,456
-96% -$474K ﹤0.01% 11252
2025
Q4
$818K Buy
528,025
+165,787
+46% +$265K ﹤0.01% 6569
2025
Q3
$572K Buy
362,238
+309,135
+582% +$537K ﹤0.01% 7566
2025
Q2
$116K Sell
53,103
-10,576
-17% -$25.6K ﹤0.01% 8891
2025
Q1
$174K Sell
63,679
-15,398
-19% -$60.7K ﹤0.01% 8546
2024
Q4
$329K Buy
79,077
+12,209
+18% +$46.1K ﹤0.01% 7585
2024
Q3
$260K Sell
66,868
-50,716
-43% -$214K ﹤0.01% 8259
2024
Q2
$461K Buy
117,584
+61,500
+110% +$265K ﹤0.01% 7155
2024
Q1
$235K Sell
56,084
-12,578
-18% -$59K ﹤0.01% 7941
2023
Q4
$323K Buy
68,662
+51,983
+312% +$202K ﹤0.01% 7487
2023
Q3
$52K Sell
16,679
-14,706
-47% -$59.1K ﹤0.01% 8145
2023
Q2
$144K Buy
31,385
+15,190
+94% +$69.8K ﹤0.01% 7831
2023
Q1
$80.2K Buy
+16,195
New +$79.7K ﹤0.01% 8318
2022
Q4
Sell
-54,081
Closed -$352K 9772
2022
Q3
$352K Buy
54,081
+27,759
+105% +$155K ﹤0.01% 7325
2022
Q2
$125K Sell
26,322
-16,510
-39% -$81.3K ﹤0.01% 8516
2022
Q1
$299K Buy
+42,832
New +$292K ﹤0.01% 8411
2021
Q4
Sell
-87,076
Closed -$1.06M 10572
2021
Q3
$1.06M Buy
+87,076
New +$1.31M ﹤0.01% 5789

Other funds holding MXCT

Jane Street's MXCT Position: Q1 2026 in Review

Jane Street reduced its MaxCyte (MXCT) stake by 96% in Q1 2026, selling an estimated $474K and leaving 20,569 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #11252.

Jane Street first reported a position in MXCT in Q3 2021 and has held it in 17 quarters since. The position peaked at $1.06M in Q3 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Jane Street held 20,569 shares of MaxCyte worth $14.4K as of Q1 2026.
  • Jane Street sold 507,456 MaxCyte shares in Q1 2026, an estimated $474K.
  • MaxCyte made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11252 holding.
  • Jane Street first reported a position in MaxCyte in Q3 2021 and has held it in 17 quarters since.
  • Jane Street's MaxCyte position peaked at $1.06M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.